S90652 in Paediatric Hypertension

• Status: Completed
• Trial end date: 2010-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut de Recherches Internationales Servier
• Treatments: Perindopril

Criteria

Inclusion Criteria:

• Hypertensive children, who have been treated for four months at least with S90652, with safety and efficacy

Exclusion Criteria:

• Poorly controlled hypertension

• Girls with signs of pubescence